Bedaquiline
- All
- News
- Videos
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert Zarir Udwadia
New Delhi: About 8,000 patients pass through Dr Zarir F Udwadia’s busy clinic every year. The patients who are usually referred to him by colleagues from different parts of the country are difficult cases of multi-drug resistant tuberculosis (MDR-TB). An expert in drug-resistant tuberculosis and interstitial lung disease (ILD), Dr Udwadia is curr...
-
Despite Winning In Court, Patna Teen Will Have To Wait Longer To Get New TB Drug
New Delhi: A Patna teenager, who is suffering from extremely drug-resistant tuberculosis, has won her right to a necessary drug in court. But it would be at least another 16 days before she has it in her hand. The delay will be due to the lengthy administrative process, which her father Kaushal Kishore Tripathi is dealing with. The teenager who ha...
-
Experts Speak On Patna Teen Girl’s Fight For TB Drug
New Delhi: Eighteen-year-old girl is fighting a battle against Tuberculosis in Patna. Her father, Kaushal Kishore Tripathi, is doing the rounds of the court, fighting to get her daughter access to a medicine that could potentially save her life. The teenager developed TB symptoms in 2011 and six years hence, she is now suffering from extremely dr...
-
Patna Teen Girl's Fight For Right To TB Drug Becomes A World Story
A teen’s court battle to gain urgent access to a new, government-controlled tuberculosis drug has become a rallying point for public health workers in India’s fight against a growing problem of drug-resistant diseases and attendant widespread health risks. The new drug, called bedaquiline, came to India last year, and it is now the only hope fo...
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
1 Indian Dies Of Tuberculosis Every Minute, No One Is Immune, Says Expert Zarir Udwadia
New Delhi: About 8,000 patients pass through Dr Zarir F Udwadia’s busy clinic every year. The patients who are usually referred to him by colleagues from different parts of the country are difficult cases of multi-drug resistant tuberculosis (MDR-TB). An expert in drug-resistant tuberculosis and interstitial lung disease (ILD), Dr Udwadia is curr...
-
Despite Winning In Court, Patna Teen Will Have To Wait Longer To Get New TB Drug
New Delhi: A Patna teenager, who is suffering from extremely drug-resistant tuberculosis, has won her right to a necessary drug in court. But it would be at least another 16 days before she has it in her hand. The delay will be due to the lengthy administrative process, which her father Kaushal Kishore Tripathi is dealing with. The teenager who ha...
-
Experts Speak On Patna Teen Girl’s Fight For TB Drug
New Delhi: Eighteen-year-old girl is fighting a battle against Tuberculosis in Patna. Her father, Kaushal Kishore Tripathi, is doing the rounds of the court, fighting to get her daughter access to a medicine that could potentially save her life. The teenager developed TB symptoms in 2011 and six years hence, she is now suffering from extremely dr...
-
Patna Teen Girl's Fight For Right To TB Drug Becomes A World Story
A teen’s court battle to gain urgent access to a new, government-controlled tuberculosis drug has become a rallying point for public health workers in India’s fight against a growing problem of drug-resistant diseases and attendant widespread health risks. The new drug, called bedaquiline, came to India last year, and it is now the only hope fo...
